Maynard Um
-
-
-
-
-
-
-
Plus CNSide diagnostic shows potential 40% healthcare cost reduction
-
-
-
-
-
-
-
Plus Therapeutics secures Highmark coverage for CNSide assay
-
-
-
-
-
-
-
Plus Therapeutics hires two executives for CNSide unit
-
-
-
-
-
-
-
Plus Therapeutics promotes executives, expands CNSide diagnostic operations
-
-
-
-
-
-
-
Plus Therapeutics meets Nasdaq equity requirement with $3 million
-
-
-
-
-
-
-
Plus Therapeutics (PSTV) begins treating patients in REYOBIQ dose optimization trial
-
-
-
-
-
-
-
Plus Therapeutics (PSTV) Files for 17M Share Offering by Selling Stockholders
-
418,486 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

